DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

30.69 -0.59 (-1.89%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $30.69 -1.89%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.92
Previous Close $31.28
Daily Range $30.54 - $31.09
52-Week Range $29.50 - $37.97
Market Cap $77.6B
P/E Ratio 30.67
Dividend (Yield) $0.90 (4.4%)
Ex-Dividend Date
Dividend Pay Date
08/12/15
09/14/15
Volume 2,266,925
Average Daily Volume 1,931,699
Current FY EPS $2.13

Sector

Healthcare

Industry

Drug Makers

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary Rss Feed

Forget Inovio's Q2 Results -- All Eyes Are Focused on These 3 Developments

Inovio handily surpassed Wall Street's estimates in Q2, but these major developments absolutely stole the show.

US Stock Futures Tumble Ahead Of Economic Data

Valeant, AstraZeneca to Partner on Brodalumab; Valeant to Make Upfront Payment to AstraZeneca of $10

Valeant, AstraZeneca to Partner on Brodalumab; Valeant to Make Upfront Payment to AstraZeneca of $100M; Up to $345M in Milestone Payments

Pfizer: A Tale Of Two Businesses

Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval

Is Now The Time To Buy AstraZeneca?

Medivation to Gain Global Rights to BioMarin's Talazoparib

AstraZeneca, Peregrine Team Up for Immuno-Oncology Study

AstraZeneca: A High-Yield Play In The Burgeoning Oncology Field

Health Care Sector Update for 08/24/2015: EPZM, VTV, AZN

US Stock Futures Tumble, China's Shanghai Plunges 8.5%

See More AZN News...

AZN's Top Competitors

AZN $30.69 (-1.89%)
Current stock: AZN
JNJ $92.09 (-2.01%)
Current stock: JNJ
NVS $94.68 (-2.61%)
Current stock: NVS
PFE $31.36 (-2.67%)
Current stock: PFE